ICF iShares Select U.S. REIT ETF

Expense Ratio
0.32%
Dividend
2.62%
Previous close
$63.23
Est. 12 months change
+11.02%
Projected Price
$70.20

Profitability Metrics

Return on Equity (ROE)
16.16%
Return on Assets (ROA)
3.42%
Return on Invested Capital (ROIC)
5.32%
Weighted Average Cost of Capital (WACC)
7.87%
ROIC - WACC
-2.56%
Updated : 2026-04-03 18:02 ET

Valuation Metrics

P/E Ratio
30.89
Forward P/E
36.09
PEG Ratio
11.72
Debt Current Ratio
1.33

Growth & Cash Flow

Gross Margin
64.96%
Operating Margin
33.65%
FCF Margin
-
TTM Revenue Growth
7.20%
Projected 12M EPS Growth
-14.40%

Price Change

Price % from 50 SMA
-0.03%
Price % from 200 SMA
2.83%
6 Months
3.15%
1 Year
2.25%
2 Years
12.89%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
EQIX9.26%
WELL8.25%
AMT7.77%
PLD7.76%
SPG5.76%
DLR4.74%
PSA4.56%
O4.45%
VTR4.24%
CCI3.82%

ETF Analysis

Fund Overview

iShares Select U.S. REIT ETF (ICF) currently reports 30 stock positions (subject to change), placing it in the balanced in breadth range by holdings breadth. The top line-up is EQIX (9.26%), WELL (8.25%), AMT (7.77%), with EQIX as the largest single weight at 9.26%. Together, the top three holdings account for 25.28%, which reflects a construction where the top positions carry meaningful but not outsized influence on aggregate returns. In aggregate, the construction reflects a balance between directional conviction and the diversification benefits that come from a broader holding set.

Profitability & Capital Efficiency

On the question of capital productivity, ROIC is 5.32%, WACC is 7.87%, and the economic spread is -2.56%. On balance, the spread between returns and funding costs is negative — a dynamic that pressures intrinsic value unless operating performance improves. Supporting metrics show ROE at 16.16% and ROA at 3.42%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio that likely needs operating improvement before returns quality can be considered durable.

Valuation

Assessed on a multiple basis, trailing P/E of 30.89, forward P/E of 36.09, PEG of 11.72. Forward P/E tracks closely with trailing P/E — a sign that the market sees the current earnings run rate as a reasonable baseline going forward. At this PEG level, the valuation case rests more on quality, scarcity, or market leadership than on earnings growth alone. The portfolio carries an aggregate current ratio of 1.33, pointing to constrained near-term balance sheet coverage. Overall, the valuation setup reads as a balance between expected growth and execution risk, with liquidity acting as an important stabilizer if macro conditions become less favorable.

Margins & Cash Generation

The margin stack reads as follows: gross margin sits at 64.96%, operating margin at 33.65%, and free cash flow margin at N/A. Gross margins at this level typically indicate businesses with structural pricing advantages and low direct cost sensitivity. At this level, operating margins reflect businesses with genuine scalability and above-average cost control. Free cash flow margin data is unavailable in the current snapshot. The margin profile is a mixed read — some holdings are clearly well-run, but the aggregate numbers point to a basket that is not uniformly high-quality.

Growth & Forward Outlook

The forward view combines two signals: the estimated 12-month price change of 11.13%, where analyst assumptions support a moderate upside case if execution remains steady, while TTM revenue growth of 7.20% suggesting the portfolio's holdings are growing revenues at a measured, sustainable pace. The forward EPS growth estimate of -14.4% is negative, which complicates the valuation case and suggests current multiples may not be as defensible on a forward basis. One metric reflects operational reality, the other market expectation — both are useful inputs, but neither should be read in isolation. The interaction between revenue execution and analyst repricing will ultimately determine how closely realized returns track current expectations. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

The quantitative review surfaces concerns across multiple dimensions — investors considering a position here should be aware of the risks and size exposures accordingly.

These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.